Recombinant Rickettsia australis gltA Protein ，His & Myc

The study of the gltA gene, which encodes the enzyme citrate synthase, has garnered significant interest in the field of microbial physiology and biochemistry due to its critical role in the Krebs cycle and overall cellular metabolism. GltA is a key enzyme that catalyzes the condensation of acetyl-CoA and oxaloacetate to form citrate, a crucial step in energy production and biosynthesis in various organisms, including bacteria and eukaryotes. Research on recombinant gltA protein has primarily focused on understanding its structure-function relationships, enzyme kinetics, and regulatory mechanisms, as alterations in gltA activity can impact metabolic pathways and cellular growth. Furthermore, gltA has been identified as a potential target for antimicrobial drug development, particularly against pathogenic bacteria, as inhibiting its function could disrupt their metabolic processes. Recombinant expression of gltA allows for detailed studies of the protein's characteristics in a controlled environment, enabling researchers to investigate its role in metabolic regulation and host-pathogen interactions. As such, the exploration of gltA recombinant proteins not only advances our fundamental understanding of metabolic processes but also opens avenues for therapeutic interventions against diseases caused by gltA-expressing organisms.